No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Biodexa Pharmaceuticals Shares Halted To The Upside; Stock Now Up 48.57%
Gaining Momentum, Biodexa Is Advancing Two Recent Acquisitions Through the Clinic
ADRs End Lower; Barinthus Biotherapeutics PLC Declines 30%
European Equities Traded in the US as American Depositary Fall Sharply in Tuesday Trading
Biodexa Pharmaceuticals Secures Nasdaq Listing Compliance
Express News | Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Regains Compliance for Continued Listing on Nasdaq